Cadila Healthcare gets tentative USFDA nod for sitagliptin 0 06.09.2021 08:53 Business Standard The drug maker on Monday announced that its subsidiary has received tentative approval from the US drug regulator for its new drug application for sitagliptin base 25, 50 and 100 mg tablets. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ